Animal Models: Dosimetry, and Pulmonary and Cardiovascular Events

EPA Grant Number: R827354C004
Subproject: this is subproject number 004 , established and managed by the Center Director under grant R827354
(EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).

Center: Airborne PM - Rochester PM Center
Center Director: Oberdörster, Günter
Title: Animal Models: Dosimetry, and Pulmonary and Cardiovascular Events
Investigators: Oberdörster, Günter , Couderc, Jean-Philippe , Cox, Christopher , Elder, Alison C.P. , Finkelstein, Jacob N. , Frampton, Mark W. , Gelein, Robert , Kreyling, Wolfgang , Morrow, P. E. , Utell, Mark J. , Zareba, Wojciech
Current Investigators: Oberdörster, Günter , Elder, Alison C.P.
Institution: University of Rochester
EPA Project Officer: Chung, Serena
Project Period: June 1, 1999 through May 31, 2005 (Extended to May 31, 2006)
RFA: Airborne Particulate Matter (PM) Centers (1999) RFA Text |  Recipients Lists
Research Category: Air Quality and Air Toxics , Particulate Matter , Air

Objective:

The objective of this research project is to improve the generation system for laboratory-generated ultrafine carbon particles, specifically, to eliminate organic contaminants and set up a separate system for the generation of ultrafine organic particles and mixed ultrafine carbon/iron particles.

Approach:

We will conduct several animal studies, to continue work on our general hypothesis that pre-existing inflammation and old age are important priming factors to sensitize the host for subsequent pulmonary and cardiovascular effects of inhaled ultrafine particles. The in vivo endpoints to be evaluated include pulmonary inflammatory markers, analysis of blood white cell adhesion molecules, blood coagulation factors, heart rate variability, and blood pressure variability (BP).

Expected Results:

We expect to be able to extend the use of our animal models to exposures of ambient ultrafine particles and organic ultrafine carbonaceous particles.

Publications and Presentations:

Publications have been submitted on this subproject: View all 33 publications for this subprojectView all 104 publications for this center

Journal Articles:

Journal Articles have been submitted on this subproject: View all 27 journal articles for this subprojectView all 90 journal articles for this center

Supplemental Keywords:

animal model, dosimetry, pulmonary, cardiovascular, ultrafine carbon particle, UFP, particulate matter, PM, electrocardiogram, ECG, hypertensive, rat, heart rate variability, HRV., RFA, Health, Scientific Discipline, Air, particulate matter, Toxicology, air toxics, Environmental Chemistry, Health Risk Assessment, Risk Assessments, Biochemistry, Atmospheric Sciences, Molecular Biology/Genetics, ambient air quality, biostatistics, health effects, particle size, particulates, risk assessment, sensitive populations, cytokine production, cardiopulmonary responses, fine particles, human health effects, lung, morbidity, ambient air monitoring, ambient air, cardiovascular vulnerability, pulmonary disease, susceptible populations, animal model, ambient monitoring, particle exposure, environmental health effects, pulmonary, lung inflamation, particulate exposure, coronary artery disease, tropospheric ozone, urban air pollution, inhalation toxicology, aerosol, cardiopulmonary, mortality, human health, urban environment, aerosols, cardiovascular disease, metals, ultrafine particles

Progress and Final Reports:

  • 1999 Progress Report
  • 2000 Progress Report
  • 2001 Progress Report
  • 2002 Progress Report
  • 2003 Progress Report
  • 2004 Progress Report
  • Final Report

  • Main Center Abstract and Reports:

    R827354    Airborne PM - Rochester PM Center

    Subprojects under this Center: (EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).
    R827354C001 Characterization of the Chemical Composition of Atmospheric Ultrafine Particles
    R827354C002 Inflammatory Responses and Cardiovascular Risk Factors in Susceptible Populations
    R827354C003 Clinical Studies of Ultrafine Particle Exposure in Susceptible Human Subjects
    R827354C004 Animal Models: Dosimetry, and Pulmonary and Cardiovascular Events
    R827354C005 Ultrafine Particle Cell Interactions: Molecular Mechanisms Leading to Altered Gene Expression
    R827354C006 Development of an Electrodynamic Quadrupole Aerosol Concentrator
    R827354C007 Kinetics of Clearance and Relocation of Insoluble Ultrafine Iridium Particles From the Rat Lung Epithelium to Extrapulmonary Organs and Tissues (Pilot Project)
    R827354C008 Ultrafine Oil Aerosol Generation for Inhalation Studies